Too many antibiotics for patients with COVID-19 despite low bacterial infections
- 27 January 2023
- journal article
- editorial
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 23 (6) , 636-637
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalised with COVID-19 (COVASP): a pragmatic, cluster-randomised, non-inferiority trialThe Lancet Infectious Diseases, 2023
- Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: A systematic review and meta-analysisPLOS ONE, 2022
- Global impact of the first year of COVID-19 vaccination: a mathematical modelling studyThe Lancet Infectious Diseases, 2022
- Early treatment to prevent progression of SARS-CoV-2 infectionThe Lancet Respiratory Medicine, 2022
- Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort studyThe Lancet Digital Health, 2022
- Antimicrobial stewardship in ICUs during the COVID-19 pandemic: back to the 90s?Intensive Care Medicine, 2020
- Co-infections in people with COVID-19: a systematic review and meta-analysisJournal of Infection, 2020
- Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial PrescribingClinical Infectious Diseases, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020